Category: Biopharmaceuticals
Global Biopharmaceuticals
-
Biopharmaceutical Bioseparation Systems
... by 2030, growing at a CAGR of 11.0% over the analysis period 2023-2030. Chromatography Technology, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$15.8 Billion by ... Read More
-
Global Biosimilar Monoclonal Antibody Market Research Report 2024(Status and Outlook)
... produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies. Biosimilar Monoclonal Antibodies refer to the biologic ... Read More
-
Biosimilars
... of 20.1% over the analysis period 2023-2030. Recombinant Non-glycosylated Proteins, one of the segments analyzed in the report, is expected to record a 20.5% CAGR and reach US$62.4 Billion by the end of the analysis ... Read More
-
Electronic Laboratory Notebooks (ELNs)
... reach US$1.0 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. Cross-disciplinary ELNs, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach ... Read More
-
Bioreactors Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Fabrication Material
... 2024-2035. Bioreactors represent specialized vessels employed in upstream biomanufacturing to foster the growth of cells and tissues under precisely controlled conditions. These conditions encompass factors like temperature, pH, pressure, aeration, and nutrient levels, all aimed ... Read More
-
Global Therapeutics Market (2024 Edition): Analysis By Molecule Type (Biologics and Biosimilars, Small Molecules), By Therapeutic Area, By Region, By Country: Market Insights and Forecast (2020-2030)
... titled Global Therapeutics Market (2024 Edition) which provides a complete analysis of the Global Therapeutics industry in terms of market segmentation By Molecule Type (Biologics and Biosimilars, Small Molecules), By Therapeutic Area (Oncology, Infectious Disease, ... Read More
-
2024 Global Biosimilars Forecast (2025-2030 Outlook)-Market Opportunities Report
... market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are published historically ... Read More
-
Single Use Bioprocessing Market Size, Share & Trends by Product (Equipment (Bioreactors, Mixers, Filtration, Chromatography), Consumables (Filters, Bags, Assemblies, Sensors)), Application, Workflow, Molecule Type (mAbs, Vaccines, CGT, Peptides) - Global
... single-use bioprocessing market is projected to reach USD 34.9 billion by 2029 from USD 17.7 billion in 2024, at a CAGR of 14.5% during the forecast period of 2024 to 2029. The growth of this ... Read More
-
Global Biologics and Biosimilars Competitive Landscape Professional Research Report 2024
... used for the treatment of various diseases, including cancer, autoimmune disorders, and genetic diseases. Biologics are often highly complex and require specialized manufacturing techniques to ensure their safety, efficacy, and consistency. Biosimilars, on the other ... Read More
-
Biopharmaceuticals Market by Product Type (Monoclonal Antibodies, Purified Proteins, Recombinant Growth Factors), Services (Compendial & Multi Compendial Laboratory Testing, Custom Testing or Customer Proprietary Testing, Laboratory Testing), Raw Material Type, Application - Global Forecast 2024-2030
... The Biopharmaceuticals Market size was estimated at USD 574.04 billion in 2023 and expected to reach USD 627.19 billion in 2024, at a CAGR 9.74% to reach USD 1,100.51 billion by 2030. Biopharmaceuticals, also known ... Read More
-
Recombinant Proteins Market by Product (Adhesion Molecules & Receptors, Growth Factors & Chemokines, Immune Response Proteins), Services (Cloning, Expression, Purification), End-User, Function - Global Forecast 2024-2030
... 5.05 billion in 2023 and expected to reach USD 5.80 billion in 2024, at a CAGR 14.51% to reach USD 13.04 billion by 2030. The recombinant proteins are created by inserting a modified gene into ... Read More
-
Clinical Trial Equipment & Ancillary Solutions Market by Product (Equipment, Services, Systems), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, End-Use, Indication - Global Forecast 2024-2030
... was estimated at USD 4.21 billion in 2023 and expected to reach USD 4.58 billion in 2024, at a CAGR 8.81% to reach USD 7.62 billion by 2030. Clinical trial equipment & ancillary solutions are ... Read More
-
Aseptic Sampling Market by Type (Automated Aseptic Sampling, Manual Aseptic Sampling), Technique (At-Line Sampling Technique, Off-Line Sampling Technique, On-Line Sampling Technique), Component, Application, End User - Global Forecast 2024-2030
... estimated at USD 968.85 million in 2023 and expected to reach USD 1,072.28 million in 2024, at a CAGR 10.96% to reach USD 2,007.50 million by 2030. Aseptic sampling is a critical process in various ... Read More
-
Clinical Trial Supply & Logistics Market by Services (Comparator Sourcing, Logistics & Distribution, Manufacturing), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, Therapeutic Area, End User - Global Forecast 2024-2030
... Logistics Market size was estimated at USD 24.33 billion in 2023 and expected to reach USD 26.20 billion in 2024, at a CAGR 7.75% to reach USD 41.04 billion by 2030. Clinical trial supply & ... Read More
-
Continuous Bioprocessing Market by Product (Bioreactors, Cell Culture Media & Reagent, Centrifuges), Process (Downstream Bioprocess, Upstream Bioprocess), Application, Scale of Operation, End-User - Global Forecast 2024-2030
... 233.44 million in 2023 and expected to reach USD 282.42 million in 2024, at a CAGR 21.30% to reach USD 902.23 million by 2030. Continuous bioprocessing represents a paradigm shift in the production of biopharmaceutical ... Read More
-
Adult Bovine Serum Market by Origin (Australia-Sourced, New Zealand-Sourced, North America-Sourced), Application (Bioprocessing, Cell Culture, Vaccine Production), End-User - Global Forecast 2024-2030
... 2023 and expected to reach USD 148.18 million in 2024, at a CAGR 5.61% to reach USD 205.99 million by 2030. Adult bovine serum (ABS) is an animal-derived serum extracted from the blood of adult ... Read More
-
Clinical Trial Supplies Market by Phase (Phase I, Phase II, Phase III), Туре (Biologic Drugs, Medical Devices, Small-Molecules), Product, Therapeutic Area, End User - Global Forecast 2024-2030
... at USD 3.35 billion in 2023 and expected to reach USD 3.64 billion in 2024, at a CAGR 8.43% to reach USD 5.92 billion by 2030. Clinical trial supplies are a fundamental yet complex component ... Read More
-
Biopharmaceutical Excipients Market by Product (Carbohydrates, Polyols, Solubilizers & Surfactants/Emulsifiers), Function (Binders, Coatings, Disintegrants), Application - Global Forecast 2024-2030
... reach USD 2.53 billion in 2024, at a CAGR 10.75% to reach USD 4.70 billion by 2030. Biopharmaceutical excipients are substances other than therapeutic molecules that are included in a biopharmaceutical formulation to aid in ... Read More
-
Insulin Market by Drug (Biologic, Biosimilar), Type (Intermediate-acting Insulin, Long-acting Insulin, Premixed Insulin), Application - Global Forecast 2024-2030
... 46.76 billion in 2024, at a CAGR 7.63% to reach USD 73.03 billion by 2030. The insulin market encompasses the production, distribution, and consumption of various insulin types used to treat diabetes mellitus, a chronic ... Read More
-
Drug Discovery Market by Drug Type (Biologic Drugs, Small Molecule Drugs), Technology (Bioanalytical Instruments, Biochips, Bioinformatics), Therapeutic Area, End User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 71.12 billion in 2024, at a CAGR 14.10% to reach USD 157.13 billion by 2030. Drug discovery is a multifaceted and intricate process that encompasses the identification of ... Read More
-
Laboratory Proficiency Testing Market by Technology (Cell Culture, Chromatography, Immunoassays), Application (Biologics, Cannabis/Opioids, Clinical Diagnostics), End-Use - Global Forecast 2024-2030
... expected to reach USD 2.39 billion in 2024, at a CAGR 7.85% to reach USD 3.77 billion by 2030. Laboratory Proficiency Testing (LPT) is a method used to evaluate and monitor the performance of laboratories ... Read More
-
Biologics Market by Source (Mammalian, Microbial), Product (Antisense & RNAi Therapeutics, Monoclonal Antibodies, Recombinant Hormones or Proteins), Indication, End-user - Global Forecast 2024-2030
... and expected to reach USD 430.59 billion in 2024, at a CAGR 6.39% to reach USD 626.34 billion by 2030. Biologics are integral to the biomedical sector, focusing on developing, manufacturing, and distributing biological treatments ... Read More
-
Global Monoclonal antibodies (mAbs) Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... USD 4812.9 million in 2023 and is forecast to a readjusted size of USD 5470.7 million by 2030 with a CAGR of 1.8% during review period. A biosimilar medicine is a medicinal product of biological ... Read More
-
Cell Therapy Human Raw Materials Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Cell Culture Media, Cell Culture Sera, Cell Culture Supplements, Reagents & Buffers, Other), By End User (Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutions), By Region and Competition, 2019-2029F
... Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutions), By Region and Competition, 2019-2029F Global Cell Therapy Human Raw Materials Market was valued at USD 3.43 Billion in 2023 and is anticipated to project steady ... Read More
-
Cell Expansion Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Consumables, Culture Flasks and Accessories, Instruments), By Cell Type (Mammalian, Human, Microbial, Others), By Application (Biopharmaceuticals, Tissue Culture & Engineering, Vaccine Production, Drug Development, Gene Therapy, Cancer Research, Stem Cell Research, Others), By End-use (Biopharmaceutical & Biotechnology Companies, Research Institutes, Cell Banks, Others), By Region and Competition, 2019-2029F
... Vaccine Production, Drug Development, Gene Therapy, Cancer Research, Stem Cell Research, Others), By End-use (Biopharmaceutical & Biotechnology Companies, Research Institutes, Cell Banks, Others), By Region and Competition, 2019-2029F Global Cell Expansion Market was valued at ... Read More
Research Assistance
